FDA Approves Incyte Eczema Cream for Kids: New Treatment
New Hope for Young Eczema Sufferers: Exploring the Future of Topical Treatments The recent FDA approval of Incyte’s Opzelura for children aged 2 to 11 marks a significant step forward in treating eczema, or atopic dermatitis. As someone who has followed the evolving landscape of dermatological treatments for years, I’m excited to delve into what … Read more